CD8A and neoplasm: Notably, gemcitabine alone and AB680+gemcitabine could significantly reduce the infiltration of MDSCs in the tumors; Besides, they also significantly decreased the fraction of overall tumor‐infiltrating CD8+ T cells (Figure S7E–H, Supporting Information).